Coating the inner surface of injection vials with polydimethylsiloxane (PDMS) primarily addresses several critical challenges related to glass surface properties and drug stability/delivery performance. The key reasons are:

1. Reduce Adsorption & Improve Drug Recovery:

   • Problem: Many therapeutic drugs (especially biologics like monoclonal antibodies, peptides, and proteins) are surface-active and prone to adsorb onto glass surfaces. This leads to:

     • Loss of effective drug dose (reduced yield).

     • Non-uniform drug concentration, impacting efficacy and safety.

     • Potential conformational changes in drug molecules affecting activity.

   • Role of PDMS: PDMS forms a hydrophobic, chemically inert layer that significantly reduces the surface energy and polarity of glass. This drastically minimizes the physical adsorption and chemical interactions of drug molecules (like proteins and peptides) with the glass, maximizing drug dose retention and activity.

2. Improve Lubricity for Smooth Delivery:

   • Problem: Untreated glass surfaces are relatively rough and hydrophilic, which can cause:

     • High friction during plunger movement in syringe barrels (high "break-loose and glide force"), resulting in difficult injection and poor user experience (especially for self-injectors).

     • Potential jamming of pre-filled syringes in auto-injector pens.

     • Increased residual drug volume after injection (as the plunger may not fully travel).

   • Role of PDMS: The PDMS coating provides excellent lubricity, significantly reducing friction between the plunger and the glass barrel. This ensures:

     • Smoother, easier plunger movement, enhancing patient compliance and experience.

     • More precise dose control.

     • Reduced drug residue, improving drug utilization.

3. Reduce Particulate Generation:

   • Problem: Vigorous friction between the plunger and dry or poorly lubricated glass can cause abrasion, generating insoluble particulates like silicone oil droplets, glass flakes, or rubber fragments. These contaminate the drug, posing safety risks (e.g., vascular occlusion, granulomas, allergic reactions).

   • Role of PDMS: By providing superior lubrication, the PDMS coating minimizes direct, harsh friction between the plunger and glass, effectively reducing the risk of particulate generation from abrasion. Compared to traditional silicone oil lubrication (see point 5), PDMS coatings are more uniform, stable, and less prone to migrating into the drug solution as droplets.

4. Enhance Chemical Inertness & Compatibility:

   • Problem: While glass itself is chemically inert, its surface contains active groups (e.g., silanol groups, Si-OH) that can potentially interact with sensitive drugs (e.g., catalyzing degradation).

   • Role of PDMS: The PDMS coating covers these active sites on the glass surface, providing a more chemically inert and biocompatible interface. This barrier reduces the likelihood of chemical interactions between the glass and the drug, enhancing drug stability.

5. Replacement/Optimization of Traditional Silicone Oil Lubrication:

   • Problems with Traditional Silicone Oil Lubrication:

     • Migration & Leaching: Sprayed or dipped silicone oil droplets readily migrate into the drug solution, forming visible or sub-visible oil droplets, contaminating the product, affecting clarity, and posing potential safety risks (e.g., allergic reactions, interference with drug analysis).

     • Non-uniformity: Silicone oil distribution can be uneven, leading to inconsistent lubrication.

     • Dose Loss: Silicone oil adsorbed onto glass can occupy space, slightly increasing drug adsorption loss.

     • Drug Interactions: Free silicone oil may interact with certain drugs (e.g., proteins), causing aggregation or inactivation.

   • Advantages of PDMS Coating:

     • Covalent Bonding/Strong Adhesion: PDMS coatings are typically cured (e.g., through baking), forming strong bonds (physical adsorption and/or partial chemical bonding) with the glass surface. This minimizes migration into the drug solution, drastically reducing oil droplet contamination risk.

     • Uniformity: Coating processes (e.g., vapor deposition, plasma treatment) enable thinner, more uniform, and controllable coatings.

     • Thinner Layer: PDMS coatings are typically much thinner (nanometer scale) than traditional silicone oil layers (micrometer scale), reducing the potential impact of the material itself on the drug.

     • Stability: The cured coating is more stable under sterilization (e.g., autoclaving) and long-term storage conditions.

In summary, the primary objectives of applying a polydimethylsiloxane (PDMS) coating to the inner surface of injection vials are to:

1. Protect the Drug: Minimize loss and inactivation of high-value, adsorption-prone drugs like biologics.

2. Ensure Safety: Reduce the risk of generating harmful particulates during delivery and minimize free silicone oil contamination.

3. Optimize Performance: Provide consistent, durable lubricity for low and uniform glide force, ensuring smooth and precise delivery while minimizing residue.

4. Enhance Compatibility: Provide a more inert and compatible surface environment for the drug.

5. Replace Traditional Silicone Oil: Overcome the drawbacks of traditional silicone oil (migration, non-uniformity, potential interactions) with a superior solution.

Therefore, PDMS coating technology has become a critical and widely adopted process in modern injectable drug packaging, especially for biologics, high-value drugs, and pre-filled syringes where requirements for lubricity, low adsorption, and low particulates are paramount.